Moderna's mRNA flu shot earns FDA approval after rollercoaster review
IT
Archived
•
August 6, 2026
•
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
Source: Ars Technica | http://feeds.arstechnica.com/arstechnica/index - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



